198 related articles for article (PubMed ID: 31243265)
1. LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1.
Ai B; Kong X; Wang X; Zhang K; Yang X; Zhai J; Gao R; Qi Y; Wang J; Wang Z; Fang Y
Cell Death Dis; 2019 Jun; 10(7):502. PubMed ID: 31243265
[TBL] [Abstract][Full Text] [Related]
2. GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation.
Shan L; Li X; Liu L; Ding X; Wang Q; Zheng Y; Duan Y; Xuan C; Wang Y; Yang F; Shang Y; Shi L
Oncogene; 2014 Jun; 33(24):3205-16. PubMed ID: 23851505
[TBL] [Abstract][Full Text] [Related]
3. LINC00473 mediates cyclin D1 expression through a balance between activation and repression signals in breast cancer cells.
Shi X; Wang X
FEBS Lett; 2019 Apr; 593(7):751-759. PubMed ID: 30848493
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the Ubiquitin-Specific Peptidase 9 X-Linked (USP9X) Gene is Associated with Upregulation of Cyclin D1 (CCND1) and Downregulation of Cyclin-Dependent Inhibitor Kinase 1A (CDKN1A) in Breast Cancer Tissue and Cell Lines.
Li H; Zheng B
Med Sci Monit; 2019 Jun; 25():4207-4216. PubMed ID: 31169265
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis.
Guo F; Fu Q; Wang Y; Sui G
J Cell Mol Med; 2019 Sep; 23(9):5907-5919. PubMed ID: 31304680
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
7. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
8. LINC01355 Contributes to Malignant Phenotype of Oral Squamous Cell Carcinoma and Cytotoxic T Cell Infiltration via Activating Notch Signaling Pathway.
Zou C; Wu S; Wei H; Luo H; Tang Z; Li X; Lv X; Ai Y
J Immunol Res; 2021; 2021():1830790. PubMed ID: 34355042
[TBL] [Abstract][Full Text] [Related]
9. LncRNA FOXD2-AS1 regulates chondrocyte proliferation in osteoarthritis by acting as a sponge of miR-206 to modulate CCND1 expression.
Cao L; Wang Y; Wang Q; Huang J
Biomed Pharmacother; 2018 Oct; 106():1220-1226. PubMed ID: 30119190
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA SNHG7 accelerates prostate cancer proliferation and cycle progression through cyclin D1 by sponging miR-503.
Qi H; Wen B; Wu Q; Cheng W; Lou J; Wei J; Huang J; Yao X; Weng G
Biomed Pharmacother; 2018 Jun; 102():326-332. PubMed ID: 29571017
[TBL] [Abstract][Full Text] [Related]
11. New insights into the roles of the
Mayahi S; Golalipour M; Yamchi A; Jhingan GD; Shahbazi M
Ups J Med Sci; 2019 Aug; 124(3):149-157. PubMed ID: 31294654
[No Abstract] [Full Text] [Related]
12. Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5/CDKN1A expression.
Ding J; Li J; Wang H; Tian Y; Xie M; He X; Ji H; Ma Z; Hui B; Wang K; Ji G
Cell Death Dis; 2017 Aug; 8(8):e2997. PubMed ID: 28796262
[TBL] [Abstract][Full Text] [Related]
13. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.
Li YL; Wang J; Zhang CY; Shen YQ; Wang HM; Ding L; Gu YC; Lou JT; Zhao XT; Ma ZL; Jin YX
Oncotarget; 2016 Sep; 7(37):59287-59298. PubMed ID: 27494902
[TBL] [Abstract][Full Text] [Related]
14. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway.
Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X
Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
Chang W; Wang Y; Li W; Shi L; Geng Z
J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052
[TBL] [Abstract][Full Text] [Related]
16. Geminin facilitates FoxO3 deacetylation to promote breast cancer cell metastasis.
Zhang L; Cai M; Gong Z; Zhang B; Li Y; Guan L; Hou X; Li Q; Liu G; Xue Z; Yang MH; Ye J; Chin YE; You H
J Clin Invest; 2017 Jun; 127(6):2159-2175. PubMed ID: 28436938
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a.
Lin C; Wu Z; Lin X; Yu C; Shi T; Zeng Y; Wang X; Li J; Song L
Clin Cancer Res; 2011 May; 17(10):3089-99. PubMed ID: 21447726
[TBL] [Abstract][Full Text] [Related]
18. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
[TBL] [Abstract][Full Text] [Related]
19. High expression of Ras-related protein 1A promotes an aggressive phenotype in colorectal cancer via PTEN/FOXO3/CCND1 pathway.
Liu L; Yan X; Wu D; Yang Y; Li M; Su Y; Yang W; Shan Z; Gao Y; Jin Z
J Exp Clin Cancer Res; 2018 Jul; 37(1):178. PubMed ID: 30064475
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of LncRNA-RP11-317J10.2 promotes cell proliferation and invasion and predicts poor prognosis in colorectal cancer.
Luo J; Xu LN; Zhang SJ; Jiang YG; Zhuo DX; Wu LH; Jiang X; Huang Y
Scand J Gastroenterol; 2018 Jan; 53(1):38-45. PubMed ID: 29073791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]